MSSA Treatment
For methicillin-susceptible Staphylococcus aureus (MSSA) infections, use cefazolin 2g IV every 8 hours or an antistaphylococcal penicillin (nafcillin/oxacillin 2g IV every 4-6 hours) as first-line therapy, with cefazolin being preferred due to its superior safety profile and comparable efficacy. 1, 2, 3
Antibiotic Selection by Clinical Scenario
Skin and Soft Tissue Infections (SSTI)
Outpatient Management:
- Simple abscesses: Incision and drainage is primary treatment; antibiotics may not be necessary for uncomplicated cases 4
- When antibiotics ARE indicated (severe/extensive disease, multiple sites, systemic illness, immunosuppression, extremes of age, difficult-to-drain locations like face/hand/genitalia): 4
- Oral options: Cephalexin 500mg every 6 hours
- Duration: 5-10 days, individualized to clinical response
Hospitalized Patients with Complicated SSTI:
- IV cefazolin 0.5-1g every 8 hours OR
- Nafcillin/oxacillin 2g every 6 hours 1
- Duration: 7-14 days based on clinical response 4
Bacteremia and Invasive Infections
Definitive therapy once MSSA confirmed:
- First-line: Cefazolin 2g IV every 8 hours OR nafcillin/oxacillin 2g IV every 4-6 hours 2, 3
- Cefazolin is generally preferred over antistaphylococcal penicillins due to better tolerability and similar efficacy 5, 6
- Duration:
- Uncomplicated bacteremia: 14 days minimum
- Complicated bacteremia (endocarditis, metastatic foci): ≥6 weeks 2
Critical caveat: For brain abscess complicating MSSA infection, nafcillin must be used instead of cefazolin due to inadequate blood-brain barrier penetration; use vancomycin if nafcillin intolerant 2
Endocarditis and Pyomyositis
- Cefazolin or antistaphylococcal penicillin (nafcillin/oxacillin) 1, 2
- Do NOT add gentamicin - combination therapy with aminoglycosides increases nephrotoxicity without improving outcomes 2
- Duration: Minimum 6 weeks for endocarditis 2
Alternative Agents
For β-lactam allergic patients:
- Vancomycin 15mg/kg IV every 12 hours (dose-adjusted to levels) 4, 1
- Daptomycin may be considered as alternative 2
Avoid these agents for serious MSSA infections:
- Second/third-generation cephalosporins (cefuroxime, ceftriaxone, cefotaxime) - associated with higher mortality compared to cefazolin/antistaphylococcal penicillins 6, 7
- Rifampin as monotherapy or adjunctive therapy for SSTI 4
- Gentamicin for right-sided or left-sided endocarditis 2
Pediatric Considerations
- Minor skin infections: Mupirocin 2% topical ointment 4
- Hospitalized children with complicated SSTI:
- Vancomycin is recommended
- Clindamycin 10-13 mg/kg/dose IV every 6-8 hours is alternative if clindamycin resistance <10% 4
- Avoid tetracyclines in children <8 years old 4
Source Control is Mandatory
Essential interventions:
- Remove infected intravascular devices and implanted hardware 3
- Drain abscesses surgically 1, 3
- Debride infected tissue 1
- Persistent bacteremia ≥48 hours warrants repeat imaging to identify undrained foci 1, 3
Imaging Requirements
All patients with MSSA bacteremia:
- Transthoracic echocardiography for all patients 3
- Transesophageal echocardiography for high-risk patients: persistent bacteremia, persistent fever, metastatic infection, implantable cardiac devices 3
- CT/MRI based on symptoms suggesting metastatic infection (back pain, joint pain, neurological symptoms) 3
Common Pitfalls
- Using ceftriaxone for serious MSSA infections - associated with worse outcomes than cefazolin 6, 7
- Adding gentamicin to β-lactams - increases nephrotoxicity without benefit 2
- Inadequate source control - antibiotics alone insufficient for persistent bacteremia 3
- Using cefazolin for CNS infections - poor CNS penetration; use nafcillin or vancomycin 2
- Empirically continuing vancomycin after MSSA confirmed - β-lactams superior to vancomycin for MSSA 2, 5